Clinical Outcomes Of A Randomized, Prospective, Phase Ii Study To Determine The Efficacy Of Bacillus Calmette-Guerin (Bcg) Given In Combination With Panvac Versus Bcg Given Alone In Adults With High Grade Bcg-Refractory Non-Muscle Invasive Bladder Cancer

JOURNAL OF UROLOGY(2021)

引用 4|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要